News
Here's Why GSK (GSK) is a Strong Value Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Is ARKO (ARKO) a Great Value Stock Right Now?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Biodesix, Inc. (BDSX) is a stock that can certainly grab the
Is SkyWest (SKYW) a Great Value Stock Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Why BP (BP) is a Top Value Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Is CarMax (KMX) Stock Undervalued Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Why Centene (CNC) is a Top Value Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are Investors Undervaluing Centerra Gold (CGAU) Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Should Value Investors Buy Wolverine World Wide (WWW) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the
Has Atlanta Braves Holdings, Inc. (BATRK) Outpaced Other Consumer Discretionary Stocks This Year?
For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Atlanta Braves Holdings (BATRK) is a stock that
Is Adecoagro (AGRO) Outperforming Other Consumer Staples Stocks This Year?
The Consumer Staples group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Adecoagro (AGRO) been one of those stocks this
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Why Cummins (CMI) is a Top Value Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
Featuring daily updates
Is FrancoNevada (FNV) Stock Outpacing Its Basic Materials Peers This Year?
For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Franco-Nevada (FNV) one of those stocks right now
Theravance Biopharma (TBPH) Q4 Earnings and Revenues Lag Estimates
Theravance Biopharma (TBPH) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to a loss of $0.05 per share a year ago. These
Is GIS' Portfolio Reshaping Strategy Key to Long-Term Growth?
General Mills, Inc. GIS continues to actively reshape the business portfolio as part of its long-term growth strategy. In line with this effort, the company recently announced a move to streamline
Zacks Industry Outlook Highlights Equity Residential and Equity LifeStyle Properties
For Immediate Release
Chicago, IL – March 19, 2026 – Today, Zacks Equity Research discusses Equity Residential EQR and Equity LifeStyle Properties ELS.
Industry: Residential REIT
Link: https://www.z
Implied Volatility Surging for Bar Harbor Bankshares Stock Options
Investors in Bar Harbor Bankshares BHB need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2026 $15.00 Call had some of the highest
Buy 3 Stocks That Announced Dividend Hikes Amid Geopolitical Tensions
Wall Street has been hit by turbulence. Rising inflation has once again raised concerns about an economic slowdown, as the Federal Reserve left interest rates unchanged on Wednesday. Also
Bank of America's Digitization Initiatives Unlocking Revenue Growth
Bank of America’s BAC push to embed artificial intelligence (AI) and digital tools deeper into its franchise is emerging as a meaningful revenue-growth lever, not just an efficiency story. Last
After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)
ResMed (RMD) has been on a downward spiral lately with significant selling pressure. After declining 12% over the past four weeks, the stock looks well positioned for a trend reversal as it is now
Down 14% in 4 Weeks, Here's Why Toyota Motor (TM) Looks Ripe for a Turnaround
A downtrend has been apparent in Toyota Motor Corporation (TM) lately with too much selling pressure. The stock has declined 14% over the past four weeks. However, given the fact that it is now in
Down 13.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Hancock Whitney (HWC)
Hancock Whitney (HWC) has been on a downward spiral lately with significant selling pressure. After declining 13.9% over the past four weeks, the stock looks well positioned for a trend reversal as
After Plunging 22.0% in 4 Weeks, Here's Why the Trend Might Reverse for Sprout Social (SPT)
Sprout Social (SPT) has been on a downward spiral lately with significant selling pressure. After declining 22% over the past four weeks, the stock looks well positioned for a trend reversal as it
Down 15.5% in 4 Weeks, Here's Why Octave Specialty (OSG) Looks Ripe for a Turnaround
Octave Specialty Group (OSG) has been on a downward spiral lately with significant selling pressure. After declining 15.5% over the past four weeks, the stock looks well positioned for a trend


